에피제네틱스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Epigenetics Market size is expected to reach USD 156.26 Billion in 2034 from USD 28.80 Billion (2025) growing at a CAGR of 20.67% during 2026-2034.

The global epigenetics market has witnessed rapid growth due to increasing research activities focused on understanding gene expression and disease mechanisms. Epigenetics studies how environmental factors and chemical modifications influence gene activity without altering the DNA sequence. Growing interest in personalized medicine and advancements in molecular biology technologies have significantly expanded the applications of epigenetics in disease diagnosis, drug discovery, and therapeutic development across the healthcare sector.

Several factors are driving the expansion of the epigenetics market. Rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has increased demand for advanced diagnostic tools and targeted treatments. Additionally, continuous advancements in genomic technologies, including sequencing and bioinformatics, are enabling researchers to study epigenetic modifications more effectively. Government funding and increasing collaboration between research institutions and biotechnology companies are also supporting market growth.

In the future, the epigenetics market is expected to grow steadily as scientific understanding of gene regulation continues to improve. The development of epigenetic therapies and precision medicine approaches may transform treatment strategies for complex diseases. Furthermore, increasing investments in biotechnology research and expanding clinical applications of epigenetic biomarkers are likely to create significant opportunities for innovation and long-term growth in this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Enzymes
• Instruments and Consumables
• Kits
• Reagents

By Application

• Oncology
• Non-Oncology

By Technology

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large non-coding RNA
• MicroRNA Modification
• Chromatin Structures

By End User

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Novartis AG, Merck KGaA, Illumina Inc, Qiagen NV, Pacific Biosciences of California Inc, Bio Techne Corporation, Promega Corporation, Zymo Research Corporation, New England Biolabs Inc, Abcam plc, Active Motif Inc, Diagenode SA, GeneTex Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EPIGENETICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EPIGENETICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EPIGENETICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. DNA Methylation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Histone Methylation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Histone Acetylation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Large non-coding RNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. MicroRNA Modification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Chromatin Structures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EPIGENETICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical Companies and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EPIGENETICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Technology
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Technology
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Technology
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Technology
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Technology
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EPIGENETICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 F. Hoffmann La Roche Ltd
  • 10.2.3 Novartis AG
  • 10.2.4 Merck KGaA
  • 10.2.5 Illumina Inc
  • 10.2.6 Qiagen N.V
  • 10.2.7 Pacific Biosciences Of California Inc
  • 10.2.8 Bio Techne Corporation
  • 10.2.9 Promega Corporation
  • 10.2.10 Zymo Research Corporation
  • 10.2.11 New England Biolabs Inc
  • 10.2.12 Abcam Plc
  • 10.2.13 Active Motif Inc
  • 10.2.14 Diagenode S.A
  • 10.2.15 GeneTex Inc